24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
Hospitals & Clinics
specialties & services
Dr. Merry Tetef graduated from the Harvard Medical School and completed her residency program at the UCLA Medical Center. She is specialized in Medical Oncology and board certified in Hematology and Oncology. Dr. Tetef has been in practice for more than 20 years and is affiliated with the Hoag Memorial Hospital Presbyterian and the Ronald Reagan UCLA Medical Center. During her career, she has also contributed to various publications of clinical interest.
AetnaBlue Cross of CaliforniaBlue Shield of CaliforniaCignaCoventry Health CareFirst Health PPOHealth NetHumanaMultiPlanTRICAREUnited Healthcare
Harvard
Medical School
UCLA Medical Center
Residency
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
Hoag Memorial Hospital Presbyterian
Languages: English/Spanish
(949) 764–4624
One Hoag Drive, P.O. Box 6100
Newport Beach, California 92658 
Ronald Reagan UCLA Medical Center
Languages: English/Spanish
(310) 825-9111
757 Westwood Plaza
Los Angeles, California 90095
St. Joseph Hospital
Languages: English/Spanish
(714) 633–9111
1100 West Stewart Drive
Orange, California 92868
Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer.
Chew, H.K., Doroshow, J.H., Frankel, P., Margolin, K.A., Somlo, G., Lenz, H., Gordon, M., Zhang, W., Yang, D., Russell, C., Spicer, D., Synold, T., Bayer, R., Hantel, ...; J Clin Oncol. 2009 May 1.
See more >>
Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to t...
Morgan, R. J., Newman, E. M., Doroshow, J. H., McGonigle, K., Margolin, K., Raschko, J., Chow, W., Somlo, G., Leong, L., Tetef, M., Shibata, S., Hamasaki, V., Carroll,...; Cancer Res. 1998 Jul 1.
See more >>
High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival.
Somlo, G., Doroshow, J. H., Forman, S. J., Odom-Maryon, T., Lee, J., Chow, W., Hamasaki, V., Leong, L., Morgan, R., Margolin, K., Raschko, J., Shibata, S., Tetef, M., ...; J Clin Oncol. 1997 Aug.
See more >>